Logo image of ZNH

CHINA SOUTHERN AIR-SPONS ADR (ZNH) Stock Fundamental Analysis

USA - NYSE:ZNH - US1694091091 - ADR

33.08 USD
+0.02 (+0.06%)
Last: 2/2/2023, 8:04:00 PM
Fundamental Rating

1

Overall ZNH gets a fundamental rating of 1 out of 10. We evaluated ZNH against 21 industry peers in the Passenger Airlines industry. ZNH may be in some trouble as it scores bad on both profitability and health. ZNH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZNH has reported negative net income.
In the past year ZNH had a positive cash flow from operations.
ZNH Yearly Net Income VS EBIT VS OCF VS FCFZNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10B -10B 20B 30B

1.2 Ratios

ZNH has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZNH Yearly ROA, ROE, ROICZNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10 -15

1.3 Margins

ZNH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZNH Yearly Profit, Operating, Gross MarginsZNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 5 -5 10 -10 15

More info and screens

0

2. Health

2.1 Basic Checks

ZNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZNH has more shares outstanding than it did 1 year ago.
ZNH has a worse debt/assets ratio than last year.
ZNH Yearly Shares OutstandingZNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
ZNH Yearly Total Debt VS Total AssetsZNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100B 200B 300B

2.2 Solvency

ZNH has an Altman-Z score of -0.12. This is a bad value and indicates that ZNH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.12, ZNH is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
ZNH has a Debt/Equity ratio of 2.23. This is a high value indicating a heavy dependency on external financing.
ZNH's Debt to Equity ratio of 2.23 is in line compared to the rest of the industry. ZNH outperforms 43.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACC7.75%
ZNH Yearly LT Debt VS Equity VS FCFZNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50B 100B

2.3 Liquidity

A Current Ratio of 0.25 indicates that ZNH may have some problems paying its short term obligations.
With a Current ratio value of 0.25, ZNH is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
A Quick Ratio of 0.23 indicates that ZNH may have some problems paying its short term obligations.
The Quick ratio of ZNH (0.23) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23
ZNH Yearly Current Assets VS Current LiabilitesZNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

More info and screens

4

3. Growth

3.1 Past

ZNH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.64%, which is quite impressive.
Looking at the last year, ZNH shows a very negative growth in Revenue. The Revenue has decreased by -11.73% in the last year.
The Revenue has been decreasing by -2.41% on average over the past years.
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-326.14%
Revenue 1Y (TTM)-11.73%
Revenue growth 3Y-10.88%
Revenue growth 5Y-2.41%
Sales Q2Q%9.01%

3.2 Future

ZNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.19% yearly.
ZNH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.70% yearly.
EPS Next Y-67.27%
EPS Next 2Y45.13%
EPS Next 3Y37.19%
EPS Next 5YN/A
Revenue Next Year-10.62%
Revenue Next 2Y18.55%
Revenue Next 3Y19.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZNH Yearly Revenue VS EstimatesZNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B
ZNH Yearly EPS VS EstimatesZNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZNH. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 59.92, which means the current valuation is very expensive for ZNH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZNH indicates a slightly more expensive valuation: ZNH is more expensive than 65.22% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.29. ZNH is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 59.92
ZNH Price Earnings VS Forward Price EarningsZNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZNH Per share dataZNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as ZNH's earnings are expected to grow with 37.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.13%
EPS Next 3Y37.19%

More info and screens

0

5. Dividend

5.1 Amount

ZNH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA SOUTHERN AIR-SPONS ADR

NYSE:ZNH (2/2/2023, 8:04:00 PM)

33.08

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-30 2022-08-30/dmh
Earnings (Next)03-30 2023-03-30/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.99B
Analysts75
Price Target36.36 (9.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-24.66%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.21%
Min EPS beat(2)11.21%
Max EPS beat(2)11.21%
EPS beat(4)2
Avg EPS beat(4)-14.54%
Min EPS beat(4)-62.02%
Max EPS beat(4)11.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)22.13%
Min Revenue beat(2)4.82%
Max Revenue beat(2)39.44%
Revenue beat(4)3
Avg Revenue beat(4)12.18%
Min Revenue beat(4)-6.11%
Max Revenue beat(4)39.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.04%
PT rev (3m)26.58%
EPS NQ rev (1m)23.58%
EPS NQ rev (3m)23.58%
EPS NY rev (1m)4.43%
EPS NY rev (3m)-18.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 59.92
P/S 0.88
P/FCF N/A
P/OCF 10.87
P/B 1.58
P/tB 1.81
EV/EBITDA N/A
EPS(TTM)-5.19
EYN/A
EPS(NY)0.55
Fwd EY1.67%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)3.04
OCFY9.2%
SpS37.79
BVpS20.89
TBVpS18.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z -0.12
F-Score3
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-326.14%
EPS Next Y-67.27%
EPS Next 2Y45.13%
EPS Next 3Y37.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.73%
Revenue growth 3Y-10.88%
Revenue growth 5Y-2.41%
Sales Q2Q%9.01%
Revenue Next Year-10.62%
Revenue Next 2Y18.55%
Revenue Next 3Y19.7%
Revenue Next 5YN/A
EBIT growth 1Y-266.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.02%
EBIT Next 3Y76.23%
EBIT Next 5YN/A
FCF growth 1Y-130.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.63%
OCF growth 3Y-11.95%
OCF growth 5Y-12.71%